Pricing Log in Create free account

Burning Rock Biotech Limited Sponsored ADR (BNR) vs MDxHealth SA (MDXH)

Burning Rock Biotech Limited Sponsored ADR and MDxHealth SA are both Diagnostics & Research companies. Burning Rock Biotech Limited Sponsored ADR is the larger, with a market value of $137.1M against $57.6M — 2.4× the size. MDxHealth SA grew revenue faster over the last twelve months: 21.5% against −0.14%. Burning Rock Biotech Limited Sponsored ADR has the higher net margin (−13.5% vs −32.5%) and the lower return on invested capital (−50.7% vs −23.8%). Across the 17 metrics below, Burning Rock Biotech Limited Sponsored ADR leads on 9 and MDxHealth SA on 8.

Valuation

Metric BNR MDXH Diagnostics & Research median
P/E n/m n/m 35.56
P/S 18.73 0.10 4.37
P/B 18.81 n/m 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m n/m 24.35
EV/Sales 17.89 0.84 5.51
Earnings yield (4.09%) (342.86%) (1.89%)
Free cash flow yield (1.06%) (63.49%) (0.15%)

Profitability

Metric BNR MDXH Diagnostics & Research median
Gross margin 74.50% 63.23% 50.89%
Operating margin (12.95%) (18.04%) (8.57%)
Net margin (13.51%) (32.53%) (6.37%)
Free cash flow margin (3.00%) (5.24%) 0.00%
Return on equity (13.08%) 238.67% (2.92%)
Return on assets (8.81%) (27.38%) (6.71%)
Return on invested capital (50.66%) (23.77%) 0.00%

Growth

Metric BNR MDXH Diagnostics & Research median
Revenue growth (TTM) (0.14%) 21.46% 7.69%
EPS growth (last fiscal year) 84.16% 42.24% 25.92%
Revenue growth, 5-year CAGR 3.21% 42.34% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNR MDXH Diagnostics & Research median
Debt to equity 0.00 (3.42) 0.11
Current ratio 3.05 1.15 2.02
Net debt to EBITDA 14.48 (10.71) 0.70

Dividend

Metric BNR MDXH Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric BNR MDXH Diagnostics & Research median
Market cap 137.12m 57.60m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack